Safety in Abdominal Aortic Aneurysm Surveillance Programs

Abdominal Aortic Aneurysm (AAA) rupture rate in the UK justifies the current surveillance programs and bring ease to some physicians that at some point have cast a shadow on their efficacy. This study also endorses reference thresholds to intervene patients.

El tratamiento endovascular parece superior a la cirugía en aneurismas rotosIn 2009, the UK National Health Service (NHS) implemented a AAA national surveillance scheme where men over 65 were eligible for screening. Those with ≥5.5 cm aneurysms were sent to consult with a vascular surgeon, while those with smaller aneurysms were invited to enter an ultrasound surveillance program.

 

AAA treatment guidelines were published in 2003, estimating a 3 to 15% rupture risk for aneurysms between 5 and 5.9 cm. More recent guidelines have estimated a 1% rupture risk a year for aneurysms under 5.5 cm.


Read also: Several Features Define a Hostile Neck in AAA patients, but Only One Makes the Difference.


This study looked at over 18,000 men between 2009 and 2017 that took part in the surveillance scheme and starting with AAA between 3 and 5.5 cm. The study did not include women, since AAA incidence in women is significantly lower.

 

During the follow up period, some 1763 patients reached 5.5 cm or higher measures and were referred to a peripheral vascular physician for definite treatment. Some 83 with smaller aneurysms were also sent to a specialist based on their symptoms, rapid growth and other alarming signs. Finally, 31 patients had aneurysm rupture, and 29 of these patients died.

 

These figures result in an estimated risk of 1 in 100 patients/year for all diameters bellow 5.5 cm.


Read also: Risk of Colonic Ischemia after Abdominal Aortic Aneurysm Repair.


Risk is in direct correlation with diameter: it goes from 0.03% for smaller aneurysms (between 3 and 4.4 cm) to 0.4% for AAA right below the reference threshold (5.0 to 5.4 cm).

 

Since rupture risk in this cohort is so low, we can conclude that the surveillance program is safe.

 

Original title: Safety of men with small and medium abdominal aortic aneurysms under surveillance in the national health service screening program.

Reference: Oliver-Williams C et al. Circulation. 2019; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...